Chemotherapy plus EGFR-TKI as first-line treatment provides better survival for advanced EGFR positive lung adenocarcinoma patients: updated data and exploratory in vitro study
Ontology highlight
ABSTRACT: To probe into the potential mechanisms contributing to the strong synergistic interaction between gefitinib and pemetrexed, gene expression profiles of PC-9 cells exposed to gefitinib, pemetrexed or combined treatment were analyzed using microarray technique.
ORGANISM(S): Homo sapiens
SUBMITTER: Yuqing Lou
PROVIDER: E-MTAB-8661 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA